Literature DB >> 29762190

Epidemiological trends in the diagnosis of melanoma in a Southern European population: analysis of a large database from a tertiary referral center.

Dimosthenis Tsoutsos1, Stefanos Papadopoulos1, George Kehagias1, Aristea Mara1, Eugenia Kyriopoulou1, Athanasios Karonidis1, Konstantinos Spiliopoulos1, Efstathios Mpalitsaris1, George Karapiperis1, Peter Panayotou1, Eugenia Papaliodi2, Theodosia Choreftaki2, George Papaxoinis3, Olga Benopoulou3, John Ioannovich1, Helen Gogas3.   

Abstract

The aim of this study was to present the epidemiological, clinicopathological, and treatment characteristics of patients diagnosed and treated in a tertiary referral center and to analyze independent factors associated with these characteristics. In this cohort study, epidemiological, clinicopathological, and treatment characteristics of 1461 consecutive melanoma patients diagnosed and treated in a tertiary referral center in 1987-2015 were prospectively collected in a registry. All patients underwent resection of their melanoma lesion. Multiple logistic regression analysis was used to examine independent correlations between characteristics. Internal validation of these correlations was performed by the bootstrap method. The median age of the patients was 53 years. Female sex had a slight predominance, whereas the majority were of Southern European origin. Superficial spreading melanoma was associated with younger age (P<0.001), whereas the nodular melanoma histological subtype was associated independently with indoor occupation (P=0.021) and diagnosis in the years 2004-2015 (P=0.002). Melanomas with Breslow thickness above 1.0 mm were associated with skin type III-IV (P=0.021) and diagnosis in the years 1987-2003 (P=0.046). In addition, histological ulceration was associated with older age (P=0.004) and diagnosis in the years 1987-2003 (P<0.001), whereas histological regression was associated independently with older age (P=0.001). This study presented independent associations between epidemiological, histopathological, and treatment characteristics, which might help to better understand melanoma disease and treatment practices in Southern Europe.

Entities:  

Mesh:

Year:  2018        PMID: 29762190     DOI: 10.1097/CMR.0000000000000456

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  3 in total

1.  Long-term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.

Authors:  Naoya Yamazaki; Yoshio Kiyohara; Hisashi Uhara; Jiro Uehara; Yasuhiro Fujisawa; Tatsuya Takenouchi; Masaki Otsuka; Hiroshi Uchi; Hironobu Ihn; Masahiro Hatsumichi; Hironobu Minami
Journal:  Cancer Sci       Date:  2019-05-23       Impact factor: 6.716

2.  Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance.

Authors:  Hisashi Uhara; Tetsuya Tsuchida; Yoshio Kiyohara; Ayumi Akamatsu; Takahiko Sakamoto; Naoya Yamazaki
Journal:  J Dermatol       Date:  2022-05-23       Impact factor: 3.468

3.  The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis.

Authors:  Zhenhua Zhang; Saber Imani; Marzieh Dehghan Shasaltaneh; Hossein Hosseinifard; Linglin Zou; Yu Fan; Qinglian Wen
Journal:  BMC Cancer       Date:  2019-11-21       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.